Comorbid pathology in patients with atrial fibrillation and pulmonary embolism
Автор: Vasiltseva O. Ya., Vorozhtsova I.N., Lavrov A.G., Karpov R.S.
Журнал: Сибирский журнал клинической и экспериментальной медицины @cardiotomsk
Рубрика: Клинические исследования
Статья в выпуске: 1 т.33, 2018 года.
Бесплатный доступ
Aims. Based on the data of the Register of new cases of pulmonary arterial thromboembolism (PE) in Tomsk hospitals (2003-2012), to study the development of thromboembolism in patients with atrial fibrillation (AF). Results. The database of the Register of new cases of hospital PE included data from patients with PE (751 people) who died in the city's hospitals and underwent autopsy. Among them, 238 patients were identified who had AF before the development of PE (in 185 patients - a permanent form of AF, in 53 - paroxysmal and persistent). Among metabolic disorders, 25% of patients showed obesity of various degrees and 27% had type 2 diabetes. Chronic heart failure 2 stages in the phase of decompensation was diagnosed in 41% of patients. The number of verified cases of PE in persons with AF did not differ significantly from patients without fibrillation and was 40%. According to autopsy data, pulmonary embolism is recognized as the main cause of death in more than half of people with AF (in 131 cases). A massive volume of pulmonary artery disease was detected in 109 patients with AF (46%). Among patients with thromboembolism from the right heart chambers, AF as a whole (regardless of form) was found in 56% of cases, that is, significantly more often than in patients with a source of embolism in the inferior vena cava (14.3%, p=0.005), veins of the lower limbs (27%, p function show_eabstract() { $('#eabstract1').hide(); $('#eabstract2').show(); $('#eabstract_expand').hide(); }
Comorbidity, pulmonary thromboembolism, atrial fibrillation, embolism sources, heart chambers, right atrial appendage
Короткий адрес: https://sciup.org/149125199
IDR: 149125199 | DOI: 10.29001/2073-8552-2018-33-1-45-49